Transcode Therapeutics Inc (RNAZ) — Defensive Interval Ratio
Transcode Therapeutics Inc (RNAZ) has a Defensive Interval Ratio of 156 days as of March 2026. Defensive assets of $2.30 Million (cash $-, short-term investments $-, receivables $2.30 Million) cover 156 days of daily cash needs of $14.74K/day. For the complete balance sheet picture, see RNAZ asset base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Transcode Therapeutics Inc Defensive Interval Ratio (2020–2025)
This chart shows how Transcode Therapeutics Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 156 days, meaning defensive assets of $2.30 Million can fund 156 days of operations without new revenue. Check asset resilience ratio of Transcode Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
Annual Defensive Interval Ratio for Transcode Therapeutics Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Transcode Therapeutics Inc from 2020 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 340 days | $3.25 Million | $9.57K/day | $- | $- | ▲ +309 days |
| 2022 | 31 days | $369.64K | $11.91K/day | $- | $9.41K | ▲ +31 days |
| 2021 | 0 days | $9.41 | $6.94K/day | $- | $9.41 | ▼ 0 days |
| 2020 | 0 days | $3.20 | $1.11K/day | $- | $3.20 | — |